Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - ArriVent BioPharma, Inc. Common Stock | StockGist | StockGist

Companies
AVBP
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings AVBPSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

ArriVent BioPharma, Inc. Common Stock

Filed Aug 14, 2025

Accepted Aug 13, 2025, 8:00 PM ET

CIK 0001868279

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

ArriVent BioPharma, Inc.

Person Type

CO

CUSIP: 0472N1020

Amendment History

6 filings

SCHEDULE 13G
Original
Oct 30, 20250000102909-25-000025
SCHEDULE 13G/A
Amendment 1
Aug 13, 20250000919574-25-004712
SCHEDULE 13G/A
Amendment 2
Viewing
Aug 14, 20250001415889-25-021943
SCHEDULE 13G/A
Amendment 3
Oct 17, 20250002012383-25-002500
SCHEDULE 13G/A
Amendment 4
Nov 5, 20250000315066-25-002677
SCHEDULE 13G/A
Amendment 5
Latest
Nov 14, 20250001214659-25-016716

Recent Filings

ArriVent BioPharma, Inc. Common Stock1 months ago

ArriVent BioPharma, Inc. Common Stock1 months ago

ArriVent BioPharma, Inc. Common Stock1 months ago

ArriVent BioPharma, Inc. Common Stock1 months ago

ArriVent BioPharma, Inc. Common Stock1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice